Mark A Sirgo's Net Worth
$16.2 Million
Who is Mark A Sirgo?
Mark A Sirgo has an estimated net worth of $16.2 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, INNOVATE BIOPHARMACEUTICALS, INC., BIOMERICA INC, and SALIX PHARMACEUTICALS LTD.
SEC CIK
Mark A Sirgo's CIK is 0001301715
Past Insider Trading and Trends
2021 was Mark A Sirgo's most active year for acquiring shares with 18 total transactions. Mark A Sirgo's most active month to acquire stocks was the month of July. 2020 was Mark A Sirgo's most active year for disposing of shares, totalling 18 transactions. Mark A Sirgo's most active month to dispose stocks was the month of December. 2014 saw Mark A Sirgo paying a total of $2,279,304.04 for 215,046 shares, this is the most they've acquired in one year. In 2015 Mark A Sirgo cashed out on 441,451 shares for a total of $7,847,741.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
President and CEOMark A Sirgo used to own units in Common Stock but no longer holds any shares there.acquired a total of 4,198,051 shares in BIODELIVERY SCIENCES INTERNATIONAL INC at a cost of $2,864,551.90, Mark also disposed a total of 4,202,449 shares of BIODELIVERY SCIENCES INTERNATIONAL INC equalling to $13,548,815.19.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.17M |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +0.66% | 7.68K |
—
|
—
| 1.17M |
Jan 27
| |||
Form 4
| +1.63% | 18.59K |
$2.69 | $49,999.03 | 1.16M |
Dec 2
| |||
Form 4/A
| +0.88% | 10K |
$3.04 | $30,400.00 | 1.14M |
Nov 18
| |||
Form 4
| +0.88% | 10K |
$3.04 | $30,400.00 | 1.14M |
Nov 18
| |||
Form 4
| +1.44% | 16K |
$3.20 | $51,200.00 | 1.13M |
Nov 11
| |||
Form 4
| +0.36% | 4K |
—
|
—
| 1.11M |
Aug 23
| |||
Form 4
| +0.36% | 4K |
—
|
—
| 1.11M |
Aug 6
| |||
Form 4
| +1.42% | 15.5K |
$3.19 | $49,380.00 | 1.11M |
May 11 - May 13
| |||
Form 4
| -15.49% | -200.00K |
$4.74 | -$948,550.00 | 1.09M |
Aug 13 - Aug 14
| |||
Form 4
| +0.31% | 4K |
—
|
—
| 1.29M |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
| -5.68% | -77.50K |
$5.07 | -$507,000.00 | 1.29M |
Scheduled
|
May 8 - May 11
| ||
Form 4
| -6.83% | -100.00K |
$4.58 | -$458,000.00 | 1.36M |
Scheduled
|
Apr 27
| ||
Form 4
| -3.30% | -50.00K |
$4.13 | -$206,500.00 | 1.46M |
Scheduled
|
Apr 15
| ||
Form 4
| +2.47% | 36.47K |
—
|
—
| 1.51M |
Mar 16
| |||
Form 4
| -0.90% | -13.35K |
$5.65 | -$75,444.45 | 1.48M |
Scheduled
|
Jan 7
| ||
Form 4
| -5.49% | -86.65K |
$6.02 | -$521,783.10 | 1.49M |
Scheduled
|
Jan 2 - Jan 6
| ||
Form 4
| -5.07% | -84.23K |
$5.15 | -$433,774.20 | 1.58M |
Scheduled
|
Oct 18
| ||
Form 4
| -7.98% | -144.09K |
$5.03 | -$724,514.38 | 1.66M |
Scheduled
|
Oct 15 - Oct 17
| ||
Form 4
| -11.09% | -225.37K |
$4.79 | -$1,078,643.79 | 1.81M |
Sep 17 - Sep 19
| |||
Form 4
| -4.27% | -90.71K |
$4.39 | -$398,199.34 | 2.03M |
Jun 25
| |||
Form 4
| -15.86% | -400.04K |
$3.95 | -$1,732,061.34 | 2.12M |
Scheduled
|
Jun 11 - Jun 12
| ||
Form 4
| +0.90% | 22.5K |
—
|
—
| 2.52M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
| +0.42% | 10.41K |
$5.20 | -$47,060.00 | 2.5M |
Scheduled
|
Mar 20 - Mar 21
| ||
Form 4
|
—
|
0
|
$3.31 | -$4,771.00 | 2.49M |
Scheduled
|
Jan 2
| ||
Form 4
| -0.40% | -10.00K |
$2.91 | -$29,100.00 | 2.49M |
Scheduled
|
Dec 27
| ||
Form 4
| +8.64% | 198.88K |
$2.06 | -$206,000.00 | 2.5M |
Scheduled
|
Apr 6 - Apr 10
| ||
Form 4
| +52.44% | 791.4K |
$2.73 | -$1,938,961.07 | 2.3M |
Scheduled
|
Jan 2 - Jan 19
| ||
Form 4
| -3.21% | -50.00K |
$2.46 | -$259,797.80 | 1.51M |
Sep 14 - Sep 21
| |||
Form 4
| +36.09% | 413.52K |
$1.90 | -$210,919.50 | 1.56M |
Scheduled
|
Mar 15 - Mar 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| +0.89% | 10.1K |
$2.63 | $26,563.00 | 1.15M |
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 29
| |||
Form 4
| +4.51% | 49K |
$3.03 | $148,470.00 | 1.14M |
Nov 30
| |||
Form 4
| +1.88% | 20K |
$2.94 | $58,800.00 | 1.09M |
Aug 18
| |||
Form 4
| +0.38% | 4K |
$7.97 | -$33,370.39 | 1.07M |
Scheduled
|
Jun 15 - Jun 16
| ||
Form 4
| +15.53% | 142.84K |
$14.25 | -$1,339,500.00 | 1.06M |
Scheduled
|
Feb 20 - Feb 25
| ||
Form 4
| +0.27% | 2.5K |
$12.23 | $30,575.00 | 923.6K |
Dec 15
| |||
Form 4
| +48.00% | 480 |
$15.90 | $7,632.00 | 1.48K |
Sep 4
| |||
Form 4
| +0.22% | 2K |
$15.04 | $30,080.00 | 922.1K |
Sep 4
| |||
Form 4
| +0.56% | 5.15K |
$3.40 | $17,499.80 | 920.1K |
Aug 26
| |||
Form 4
| +0.19% | 1.71K |
$8.88 | $15,140.40 | 914.96K |
Mar 19
| |||
Form 4
| +12.02% | 98K |
$8.91 | $871,360.00 | 913.25K |
Scheduled
|
Feb 20
| ||
Form 4
| -6.74% | -58.93K |
$5.51 | -$932,218.29 | 815.25K |
Scheduled
|
Jan 24
| ||
Form 4
| +0.27% | 2.34K |
$4.29 | $10,025.73 | 874.18K |
Nov 18
| |||
Form 4
| +0.59% | 5.1K |
$4.43 | $22,615.00 | 871.84K |
Aug 14 - Aug 16
| |||
Form 4
| +0.39% | 3.4K |
$4.30 | $14,630.00 | 866.74K |
Jun 17 - Jun 21
| |||
Form 4
| +0.40% | 3.45K |
$4.51 | $15,541.46 | 863.34K |
May 29
| |||
Form 4
| +0.58% | 4.97K |
$4.02 | $20,023.75 | 859.9K |
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9 - Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +3.21% | 26.66K |
$2.35 | $62,597.76 | 856.72K |
Mar 25
| |||
Form 4
| +0.37% | 3.03K |
$3.29 | $9,981.00 | 830.06K |
Feb 21 - Mar 15
| |||
Form 4
| +0.53% | 4.38K |
$2.26 | $9,896.95 | 827.03K |
Aug 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21 - Jul 22
| |||
Form 4
| +0.49% | 4.02K |
$2.53 | $10,175.66 | 822.65K |
Jun 9
| |||
Form 4
| +0.55% | 4.45K |
$2.86 | $12,727.00 | 818.63K |
May 21
| |||
Form 4/A
| +0.43% | 3.5K |
$3.29 | $11,530.00 | 814.17K |
May 13 - May 14
| |||
Form 4
| +0.43% | 3.5K |
$3.29 | $11,530.00 | 814.17K |
May 13 - May 14
| |||
Form 4
| +0.31% | 2.5K |
$4.02 | $10,045.00 | 810.67K |
Mar 24 - Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| -3.58% | -30.00K |
$6.67 | -$200,000.00 | 808.17K |
Scheduled
|
Jun 5
| ||
Form 4
| -2.33% | -20.00K |
$6.01 | -$120,181.50 | 838.17K |
Scheduled
|
Jun 3 - Jun 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| +0.46% | 3.83K |
$2.76 | $10,586.82 | 834.27K |
Sep 18 - Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
| +0.73% | 6K |
$2.41 | $14,460.00 | 830.44K |
Mar 12 - Mar 13
| |||
Form 4
| +0.55% | 4.5K |
$3.11 | $13,995.00 | 824.44K |
Nov 19 - Nov 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27 - Jul 28
| |||
Form 4
| +0.27% | 2.23K |
$4.55 | $10,146.50 | 819.94K |
Jun 18
| |||
Form 4
| +3,928.14% | 797.41K |
—
|
—
| 817.71K |
Jan 26 - May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +230.00% | 13.8K |
$2.08 | $28,747.00 | 19.8K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
|
∞
| 6K |
$2.16 | $12,965.00 | 6K |
Aug 23 - Sep 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001
InvestorMark A Sirgo owns 85,907 units of Common stock which is worth $0.09.acquired a total of 1,753,871.55 shares in INNOVATE BIOPHARMACEUTICALS, INC. at a cost of $978,207.66.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.11% | 7.88K |
—
|
—
| 85.91K |
Mar 29
| |||
Form 4/A
| +12.63% | 175K |
$0.25 | $42,962.50 | 1.56M |
Jul 1
| |||
Form 4
| +13.68% | 175K |
$0.25 | $42,962.50 | 1.45M |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +8.32% | 106.38K |
$0.47 | $50,000.01 | 1.39M |
May 18
| |||
Form 4
| +7.25% | 86.45K |
$0.58 | $50,002.42 | 1.28M |
Mar 3
| |||
Form 4
| +4.19% | 50K |
$0.89 | $44,500.00 | 1.24M |
Dec 2
| |||
Form 4
| +1.71% | 20K |
$1.06 | $21,200.00 | 1.19M |
Nov 18
| |||
Form 4
| +6.69% | 73.53K |
$1.36 | $99,999.44 | 1.17M |
Sep 7
| |||
Form 4
| +2.33% | 25K |
$1.10 | $27,500.00 | 1.1M |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +38.76% | 300K |
$1.00 | $300,000.00 | 1.07M |
Apr 5
| |||
Form 4
| +42.48% | 230.77K |
$0.65 | $149,999.85 | 774.07K |
Dec 15
| |||
Form 4
| +0.84% | 4.51K |
—
|
—
| 543.3K |
Oct 30
| |||
Form 4
| +36.06% | 148.49K |
$0.65 | $96,363.92 | 560.27K |
Sep 10 - Sep 11
| |||
Form 4
| +32.07% | 100K |
$0.56 | $56,000.00 | 411.78K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
| +443.33% | 254.4K |
—
|
—
| 311.78K |
Jun 30
| |||
Form 4
| +45.49% | 17.94K |
$0.60 | $10,720.94 | 57.38K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOMERICA INC (BMRA) Snapshot price: $0.34
InvestorMark A Sirgo owns 8,700 units of Common Stock which is worth $2,958.00. In the year 2016 Mark A Sirgo filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
| -53.48% | -10.00K |
$8.09 | -$80,877.52 | 8.7K |
Apr 17 - Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +55.83% | 6.7K |
$3.73 | $24,991.00 | 18.7K |
May 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +50.00% | 4K |
$2.05 | $8,200.00 | 12K |
Aug 3
| |||
Form 4
|
∞
| 8K |
$1.97 | $15,745.00 | 8K |
Aug 1 - Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SALIX PHARMACEUTICALS LTD No price found
InvestorMark A Sirgo owns 36,706 units of Commmon Stock. Mark A Sirgo used to own units in Common Stock but no longer holds any shares there. From 2009 to 2014 Mark A Sirgo acquired a total of 65,826 shares in SALIX PHARMACEUTICALS LTD at a cost of $1,058,165.60, Mark also disposed a total of 67,326 shares of SALIX PHARMACEUTICALS LTD equalling to $7,509,703.51.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -37.43K |
$173.00 | -$6,474,871.00 |
0
|
Apr 1
| |||
Form 4
| +9.30% | 3.19K |
$158.30 | $504,185.50 | 37.43K |
Aug 22
| |||
Form 4
| +10.26% | 3.19K |
$100.66 | $320,602.10 | 34.24K |
Apr 17
| |||
Form 4
| -6.07% | -2.01K |
$54.00 | -$108,432.00 | 31.06K |
Scheduled
|
May 3
| ||
Form 4
| +14.19% | 4.11K |
$48.70 | $200,157.00 | 33.06K |
Apr 18
| |||
Form 4
| -9.39% | -3.00K |
$50.05 | -$150,150.00 | 28.95K |
Scheduled
|
Mar 20
| ||
Form 4
| -8.58% | -3.00K |
$46.19 | -$138,570.00 | 31.95K |
Scheduled
|
Jan 11
| ||
Form 4
| -8.98% | -3.45K |
$40.53 | -$139,811.25 | 34.95K |
Nov 12 - Nov 13
| |||
Form 4
| +12.15% | 4.16K |
—
|
—
| 38.41K |
Apr 5
| |||
Form 4
| -4.03% | -1.44K |
$47.85 | -$68,856.15 | 34.24K |
Jan 3
| |||
Form 4
| -3.65% | -1.35K |
$39.83 | -$53,850.16 | 35.68K |
Jul 1
| |||
Form 4
| -4.33% | -1.68K |
$38.93 | -$65,207.75 | 37.04K |
May 27
| |||
Form 4
| +13.62% | 4.64K |
—
|
—
| 38.71K |
Apr 25
| |||
Form 4
| -4.69% | -1.68K |
$32.40 | -$54,270.00 | 34.07K |
Mar 10
| |||
Form 4
| +13.89% | 4.36K |
—
|
—
| 35.75K |
Jul 19
| |||
Form 4
| -10.72% | -3.77K |
$39.03 | -$147,143.10 | 31.39K |
Jul 1
| |||
Form 4
| -4.22% | -1.55K |
$29.26 | -$45,353.00 | 35.16K |
Feb 4
| |||
Form 4
| +0.55% | 400 |
$27.49 | $10,996.00 | 73.21K |
Jan 6 - Jan 15
| |||
Form 4
| +2.69% | 950 |
$12.46 | $11,840.00 | 36.31K |
Aug 14
| |||
Form 4
| +30.34% | 8.23K |
$9.87 | -$38,789.10 | 35.36K |
Jul 1
| |||
Form 4
| +3.83% | 1K |
$10.39 | $10,385.00 | 27.13K |
May 8
| |||
Form 4/A
| -5.60% | -1.55K |
$8.00 | -$12,400.00 | 26.13K |
Feb 2
| |||
Form 4
| -5.42% | -1.50K |
$8.00 | -$12,000.00 | 26.18K |
Feb 2
| |||
Form 4
| +84.51% | 12.68K |
—
|
—
| 27.68K |
Jul 1
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||